Trinity Legacy Partners LLC Has $414,000 Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Trinity Legacy Partners LLC reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.5% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 850 shares of the medical equipment provider’s stock after selling 156 shares during the period. Trinity Legacy Partners LLC’s holdings in Intuitive Surgical were worth $414,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in ISRG. Hazlett Burt & Watson Inc. raised its holdings in Intuitive Surgical by 5.8% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after purchasing an additional 20 shares during the last quarter. Ullmann Wealth Partners Group LLC raised its stake in shares of Intuitive Surgical by 1.6% during the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after buying an additional 21 shares during the last quarter. One Wealth Management Investment & Advisory Services LLC lifted its holdings in Intuitive Surgical by 3.4% in the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after buying an additional 23 shares during the period. Falcon Wealth Planning boosted its stake in Intuitive Surgical by 0.4% in the third quarter. Falcon Wealth Planning now owns 5,693 shares of the medical equipment provider’s stock valued at $2,797,000 after acquiring an additional 23 shares during the last quarter. Finally, Daymark Wealth Partners LLC boosted its stake in Intuitive Surgical by 0.3% in the third quarter. Daymark Wealth Partners LLC now owns 7,027 shares of the medical equipment provider’s stock valued at $3,452,000 after acquiring an additional 24 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the sale, the chief executive officer now owns 24,219 shares in the company, valued at $12,391,166.97. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. In other news, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at $1,461,006.84. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 68,246 shares of company stock worth $33,839,308 over the last ninety days. 0.90% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on ISRG shares. Stifel Nicolaus increased their price target on Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Truist Financial increased their target price on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Citigroup upped their price target on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Finally, Leerink Partners lifted their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $524.28 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $269.49 and a fifty-two week high of $525.00. The stock has a market capitalization of $186.74 billion, a price-to-earnings ratio of 84.29, a PEG ratio of 4.99 and a beta of 1.39. The business has a 50-day moving average of $492.30 and a 200-day moving average of $450.05.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.